New Hope for Patients Waiting for a Kidney Transplant: Promising Results from Major Study
A recent study presented at a major kidney health conference (ASN Kidney Week 2026) has shown encouraging results for people […]
Pharmaceutical News
How GlobalData Handles Your Personal Information: A Clear and Simple Guide
Hello! I’m your pharmacist, and today I’ll explain GlobalData’s privacy policy in plain language so you understand how they protect
FDA Approves New Treatment for Chronic Hepatitis B That Could Offer a Long-Term Cure
The U.S. Food and Drug Administration (FDA) has approved a new medication called Hibsago (also known as bepirovirsen) for adults
Pharmaceutical News
New Treatment Shows Promise for Advanced Neuroendocrine Tumors
A new cancer treatment called RYZ101 has shown promising results in a clinical trial for patients with advanced neuroendocrine tumors
Pharmaceutical News
New Oral Drug SUN-627 Shows Promise for Progressive Multiple Sclerosis in Early Trial Results
A new oral medication called SUN-627, developed by Sundance Biosciences, has shown encouraging results in early human testing for treating
Pharmaceutical News
New Hope for Patients with Advanced Pancreatic Cancer: EMA Recommends First Targeted Oral Treatment
A major European health agency, the European Medicines Agency (EMA), has recommended approving a new once-daily tablet called Rasonque (daraxonrasib)
New Medicine Shows Promise for Severe Eczema in Early Trial
A biotechnology company called Sitryx Therapeutics has shared exciting early results from a small clinical trial of a new medicine
New Flu Vaccine Shows Promise but Needs More Work, Study Finds
A new experimental flu vaccine called OVX836 has completed a large clinical trial involving 2,850 healthy adults in Europe. This
Pharmaceutical News
Boehringer Ingelheim and Microsoft Team Up to Use AI in Medicine Development for Faster Patient Access
Boehringer Ingelheim, a pharmaceutical company, and Microsoft have announced a partnership to explore how artificial intelligence (AI) can improve the
New Migraine Treatment Option Approved for NHS Scotland Patients
AbbVie has received approval for a new migraine treatment called AQUIPTA (atogepant) to be used by adults in NHS Scotland,